🇺🇸 FDA
Patent

US 11512128

VEGF/DLL4 binding agents and uses thereof

granted A61KA61K2039/505A61K31/4745

Quick answer

US patent 11512128 (VEGF/DLL4 binding agents and uses thereof) held by MEREO BIOPHARMA 5, INC. expires Mon Nov 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
MEREO BIOPHARMA 5, INC.
Grant date
Tue Nov 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K2039/505, A61K31/4745, A61K31/7068, A61K39/00